Immix Biopharma

Immix Biopharma is a biopharmaceutical company developing therapies for cancer patients. It offers Imx-110, a combination therapy designed to inhibit cancer resistance and evolvability while inducing apoptosis. Imx-110 contains NF-kB/Stat3/pan-kinase inhibitor curcumin combined with a small amount of doxorubicin encased in a nano-sized delivery system for optimal tumor penetration.